TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23816271

Group type: EXPERIMENTAL
Intervention: pegylated interferon α 2b
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: pegylated interferon α 2a
Number of subjects: 57

Group type: COMPARATOR
Intervention: pegylated interferon α 2b and α 2a
Number of subjects: 57
Study: 21238470

Group type: EXPERIMENTAL
Intervention: Eating at a fast rate (FM) - 7 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eating at a medium rate (MM) - 14 minutes
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eating at a slow rate (SM) - 28 minutes
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ad libitum energy intake at the next meal
Number of subjects: 25
Study: 19127178

Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Experimental (EXP) group
Number of subjects: 18
Study: 17917321

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg plus Hydrochlorothiazide 12.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg plus Hydrochlorothiazide 6.25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan 25 mg plus Hydrochlorothiazide 6.25 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan 50 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15536109

Group type: EXPERIMENTAL
Intervention: Carvedilol (6.25-25 mg, twice daily)
Number of subjects: 1235

Group type: COMPARATOR
Intervention: Metoprolol tartrate (50-200 mg, twice daily)
Number of subjects: 1235

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1235

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 1235
Study: 11870676

Group type: COMPARATOR
Intervention: Flunisolide CFC 1000 microg bid
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Flunisolide HFA 170 microg bid
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Flunisolide HFA 340 microg bid
Number of subjects: 31

Group type: COMPARATOR
Intervention: Flunisolide CFC
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Flunisolide HFA
Number of subjects: 31
Study: 9121940

Group type: EXPERIMENTAL
Intervention: 15% low-fat diet
Number of subjects: 194

Group type: COMPARATOR
Intervention: Nonintervention usual diet
Number of subjects: 194
Study: 7942779

Group type: EXPERIMENTAL
Intervention: Serum vitamin B12 levels in asymptomatic HIV seropositive patients
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Unsaturated B12 binding capacities of transcobalamins I and II in asymptomatic HIV seropositive patients
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Clinical progression to ARC or AIDS in asymptomatic HIV seropositive patients
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: CD4 counts in asymptomatic HIV seropositive patients
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Serum B12 levels over 2 1/2 years in asymptomatic HIV seropositive patients
Number of subjects: 218
Study: 3330987

Group type: EXPERIMENTAL
Intervention: Immediate-release (IR) verapamil
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sustained-release (SR) verapamil
Number of subjects: 58
Study: 31702397

Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Number of subjects: 77

Group type: COMPARATOR
Intervention: Hospital-based cardiac rehabilitation
Number of subjects: 77
Study: 30974306

Group type: EXPERIMENTAL
Intervention: Community-Based Rehabilitation (CBR) intervention using psychoeducation and social skill modules for 12 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Community-Based Rehabilitation (CBR) intervention.
Number of subjects: 100
Study: 28368183

Group type: EXPERIMENTAL
Intervention: Focused Academic Strength Training (FAST)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 72
Study: 26087214

Group type: EXPERIMENTAL
Intervention: TVT-O procedure
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: AJUST procedure
Number of subjects: 100
Study: 23909568

Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 12 hours
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 24 hours
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 48 hours
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 72 hours
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Mechanical removal of plaque every 48 and 72 hours
Number of subjects: 52
Study: 21166828

Group type: EXPERIMENTAL
Intervention: Emdogain Gel (Biora AB, Malmö, Sweden)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Calcium hydroxide
Number of subjects: 18
Study: 18436034

Group type: EXPERIMENTAL
Intervention: Cone-beam tomography (CBT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Periapical radiography (PA)
Number of subjects: 74
Study: 16525002

Group type: EXPERIMENTAL
Intervention: Six-session social skills intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Two-hour standard HIV educational session
Number of subjects: 92
Study: 15095765

Group type: EXPERIMENTAL
Intervention: Cochrane Controlled Trials Register
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MEDLINE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Embase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Science/Social Sciences Citation Index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional databases searched after CCTR, MEDLINE, and Embase
Number of subjects: 0

Group type: COMPARATOR
Intervention: CCTR, MEDLINE, and Embase
Number of subjects: 0
Study: 11344463

Group type: EXPERIMENTAL
Intervention: Random tickets
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Perceived randomness
Number of subjects: 60
Study: 9469526

Group type: EXPERIMENTAL
Intervention: Hypnosis (HYP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Stress reducing strategies (CONT)
Number of subjects: 60
Study: 7934491

Group type: EXPERIMENTAL
Intervention: 1 mg/kg cA2
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 10 mg/kg cA2
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 2904392

Group type: EXPERIMENTAL
Intervention: sulphasalazine 2 g/day
Number of subjects: 23

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study: 31143466

Group type: EXPERIMENTAL
Intervention: Psychological First Aid (PFA) training
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Short training programmes for PFA
Number of subjects: 72
Study: 27673360

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH, 32‐34°C)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Fever control (35.5‐37.0°C)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: All patients (combined analysis)
Number of subjects: 148
Study: 25263400

Group type: EXPERIMENTAL
Intervention: 2-stage surgical technique
Number of subjects: 67

Group type: COMPARATOR
Intervention: 1-stage surgical technique
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Bone grafting
Number of subjects: 67
Study: 23886756

Group type: EXPERIMENTAL
Intervention: Routines-based early intervention (RBEI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Traditional home visiting (THV)
Number of subjects: 31
Study: 21729166

Group type: EXPERIMENTAL
Intervention: 311 nm UVB therapy
Number of subjects: 4

Group type: COMPARATOR
Intervention: Non-irradiated body halves
Number of subjects: 4
Study: 19479151

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields
Number of subjects: 483

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study: 16916540

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 163
Study: 15321432

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 565

Group type: COMPARATOR
Intervention: 0.2% ropivacaine
Number of subjects: 565
Study: 10903487

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 200 microg once daily
Number of subjects: 904

Group type: COMPARATOR
Intervention: Fluticasone propionate 100 microg twice daily
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 500 microg once daily
Number of subjects: 904

Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg twice daily
Number of subjects: 904

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (both regimens)
Number of subjects: 904
Study: 9018514

Group type: EXPERIMENTAL
Intervention: Topical upper airway anesthesia with 0.2% tetracaine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sham anesthesia (Control)
Number of subjects: 7
Study: 1549927

Group type: EXPERIMENTAL
Intervention: 1 min preoxygenation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 3 min preoxygenation
Number of subjects: 11
Study: 4073600

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol canister with new longer, snout-like nozzle adapters
Number of subjects: 48

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate aerosol canister with currently available delivery system
Number of subjects: 48
Study: 31886216

Group type: EXPERIMENTAL
Intervention: Cognitive training intervention group (N=70)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (N=70)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Cognitive training intervention
Number of subjects: 140
Study: 29864430

Group type: EXPERIMENTAL
Intervention: Oral glucosamine hydrochloride (1.44 g/day) combined with hyaluronate sodium injections
Number of subjects: 144

Group type: COMPARATOR
Intervention: Oral placebo combined with hyaluronate sodium injections
Number of subjects: 144
Study: 27798329

Group type: EXPERIMENTAL
Intervention: Whole-grain diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Refined-grain diet (Control)
Number of subjects: 40
Study: 23763270

Group type: EXPERIMENTAL
Intervention: Topical nicotinamide (NCT) 4% cream
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (vehicle without NCT)
Number of subjects: 48
Study: 22387875

Group type: EXPERIMENTAL
Intervention: 6-week strengthening and stretching intervention program (3 times per week)
Number of subjects: 44
Study: 19828470

Group type: EXPERIMENTAL
Intervention: Mepolizumab (750 mg, n = 5)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mepolizumab (1500 mg, n = 5)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 17286233

Group type: EXPERIMENTAL
Intervention: Elevated CRP levels
Number of subjects: 141

Group type: COMPARATOR
Intervention: IL-6G(-174)C genotype
Number of subjects: 141

Group type: COMPARATOR
Intervention: IL1RA genotype
Number of subjects: 141

Group type: COMPARATOR
Intervention: CRP levels
Number of subjects: 141
Study: 16128937

Group type: EXPERIMENTAL
Intervention: IL1RN*2 allele carriers
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Two‐variant allele carriers who were also homozygous for the IL1B‐31*T allele
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Haplotype IL1RN*2/IL1B‐31*T
Number of subjects: 731
Study: 12143913

Group type: EXPERIMENTAL
Intervention: Paroxetine controlled-release (CR) 25-62.5 mg/day
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Paroxetine immediate-release (IR) 20-50 mg/day
Number of subjects: 640

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Paroxetine CR
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Paroxetine IR
Number of subjects: 640
Study: 9929085

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity program
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Structured exercise program
Number of subjects: 235
Study: 9868616

Group type: EXPERIMENTAL
Intervention: Silver-coated medical devices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silver preparations in burns
Number of subjects: 0
Study: 1832454

Group type: EXPERIMENTAL
Intervention: 500 mg naproxen b.i.d. for 3 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 6623556

Group type: EXPERIMENTAL
Intervention: Neutron irradiation
Number of subjects: 115

Group type: COMPARATOR
Intervention: Photon irradiation
Number of subjects: 115
Study: 30716790

Group type: EXPERIMENTAL
Intervention: Early Calsurf administration (n=154)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Rescue Calsurf administration (n=151)
Number of subjects: 305
Study: 29396276

Group type: EXPERIMENTAL
Intervention: High alcohol levels (0.6gL-1)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Postcall surgeons
Number of subjects: 18
Study: 27679519

Group type: EXPERIMENTAL
Intervention: Combination therapy with losartan and lisinopril
Number of subjects: 1148

Group type: COMPARATOR
Intervention: Monotherapy with losartan
Number of subjects: 1148
Study: 24910383

Group type: EXPERIMENTAL
Intervention: Lipid garlic extract (LGE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study: 22682697

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (25 NHs)
Number of subjects: 4515

Group type: COMPARATOR
Intervention: Assessment only (25 NHs)
Number of subjects: 4515

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 4515
Study: 20135623

Group type: EXPERIMENTAL
Intervention: Spinal orthosis (Thämert Osteo‐Med) for 6 months
Number of subjects: 72

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 72
Study: 18614558

Group type: EXPERIMENTAL
Intervention: Group asthma education-exercise programme
Number of subjects: 36
Study: 16027537

Group type: EXPERIMENTAL
Intervention: CD-ROM educational program for sexual violence prevention (n = 39)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (n = 40)
Number of subjects: 79
Study: 12516830

Group type: EXPERIMENTAL
Intervention: CAF+EMD group (Emdogain with coronally advanced flap)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CAF+CTG+EMD group (Emdogain with coronally advanced flap and subepithelial connective tissue graft)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CAF+EMD group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CAF+CTG+EMD group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 10636368

Group type: EXPERIMENTAL
Intervention: Information video
Number of subjects: 150

Group type: COMPARATOR
Intervention: No video
Number of subjects: 150
Study: 7492835

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2019772

Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin (CA)
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Ceftazidime plus amikacin plus vancomycin (CAV)
Number of subjects: 747
Study: 6160345

Group type: EXPERIMENTAL
Intervention: Low-dose furosemide (40 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal controls (no therapy)
Number of subjects: 12
Study: 31116151

Group type: EXPERIMENTAL
Intervention: Doxazosin mesylate GITS (4 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nifedipine GITS (30 mg/day)
Number of subjects: 36
Study: 28694153

Group type: EXPERIMENTAL
Intervention: Sugar-free energy drink (SFED)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dummy drink (control)
Number of subjects: 14
Study: 25928214

Group type: EXPERIMENTAL
Intervention: Intravenous steroids
Number of subjects: 1695

Group type: EXPERIMENTAL
Intervention: DrotAA + steroids
Number of subjects: 1695

Group type: EXPERIMENTAL
Intervention: Placebo + steroids
Number of subjects: 1695

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1695
Study: 23648079

Group type: EXPERIMENTAL
Intervention: Multifaceted program for MRSA infection prevention
Number of subjects: 159
Study: 21896127

Group type: EXPERIMENTAL
Intervention: Lipohydroxyacid peels
Number of subjects: 20

Group type: COMPARATOR
Intervention: Salicylic acid peels
Number of subjects: 20
Study: 20043571

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Therapeutic ultrasound (US)
Number of subjects: 10
Study: 17207038

Group type: EXPERIMENTAL
Intervention: Hypothetical preventer medication
Number of subjects: 57

Group type: COMPARATOR
Intervention: Current inhaled corticosteroid medication
Number of subjects: 57

Group type: COMPARATOR
Intervention: No asthma medication
Number of subjects: 57
Study: 15146933

Group type: EXPERIMENTAL
Intervention: Epinastine hydrochloride (20 mg/day, once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11464687

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure measurements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blood pressure measurements in the surgery
Number of subjects: 0
Study: 9847466

Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiotherapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 58
Study: 8017354

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (beta-lactose)
Number of subjects: 77
Study: 2137406

Group type: EXPERIMENTAL
Intervention: Hulka clip via laparoscopy
Number of subjects: 499

Group type: COMPARATOR
Intervention: Unipolar electrocoagulation (cautery) via laparoscopy
Number of subjects: 499

Group type: COMPARATOR
Intervention: Tubal ring occlusion technique
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Overall satisfaction with sterilization procedure
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Pelvic or abdominal surgeries post-sterilization
Number of subjects: 499
Study: 29697447

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy (LG)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Open gastrectomy (OG)
Number of subjects: 610
Study: 28042082

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BR)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Chard gel (GEL)
Number of subjects: 9
Study: 26187617

Group type: EXPERIMENTAL
Intervention: FOLFOX
Number of subjects: 3018
Study: 24053706

Group type: EXPERIMENTAL
Intervention: SLIT (sublingual immunotherapy)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SCIT (subcutaneous immunotherapy)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21703676

Group type: EXPERIMENTAL
Intervention: Outpatient treatment with subcutaneous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Inpatient treatment with subcutaneous enoxaparin (≥5 days) followed by oral anticoagulation (≥90 days)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 344

Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 344
Study: 19231298

Group type: EXPERIMENTAL
Intervention: Qigong (24 sessions over 3 months)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Exercise therapy (24 sessions over 3 months)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 117
Study: 17960627

Group type: EXPERIMENTAL
Intervention: Mynx extravascular sealant
Number of subjects: 190
Study: 15142202

Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg am and 30 mg pm for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 40
Study: 11114574

Group type: EXPERIMENTAL
Intervention: L-carnitine (500 mg/day) for 3 months
Number of subjects: 14
Study: 9496487

Group type: EXPERIMENTAL
Intervention: Standardized oral desensitization program
Number of subjects: 14

Group type: COMPARATOR
Intervention: Strict elimination diet regimen (Control)
Number of subjects: 14
Study: 7766945

Group type: EXPERIMENTAL
Intervention: Phenylalanine-restricted diet, maintaining maternal blood phenylalanine levels between 120 and 360 mumol/l before conception and during pregnancy.
Number of subjects: 402
Study: 2924230

Group type: EXPERIMENTAL
Intervention: Involvement in establishing criteria (15 physicians)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Receiving criteria by mail (15 physicians)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (10 physicians)
Number of subjects: 40
Study: 1123173

Group type: EXPERIMENTAL
Intervention: Metiamide (histamine H2-receptor antagonist)
Number of subjects: 0
Study: 31537420

Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: suxamethonium 1 mg/kg
Number of subjects: 90
Study: 31102925

Group type: EXPERIMENTAL
Intervention: Thai Boxing dance (TBD) program for 4 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group receiving a fall prevention booklet
Number of subjects: 78
Study: 28617540

Group type: EXPERIMENTAL
Intervention: PM2.5 group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: House dust mite antigen group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Synergistic group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study: 25848237

Group type: EXPERIMENTAL
Intervention: Psychoeducation with Behavioral Activation (PsyED-BA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Psychoeducation only (PsyED only)
Number of subjects: 62
Study: 23623520

Group type: EXPERIMENTAL
Intervention: Discharge coordinator intervention
Number of subjects: 253

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 253
Study: 21719783

Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg/d
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 19700995

Group type: EXPERIMENTAL
Intervention: Coaptive film (Steri Strip S; 3M company)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Subcuticular monocryl sutures (4‐0 intracuticular monocryl sutures)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Coaptive film
Number of subjects: 8

Group type: COMPARATOR
Intervention: Subcuticular monocryl sutures
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Coaptive film and Subcuticular monocryl sutures
Number of subjects: 8
Study: 16676704

Group type: EXPERIMENTAL
Intervention: H‐Pro (high protein diet)
Number of subjects: 7

Group type: COMPARATOR
Intervention: H‐CHO (high carbohydrate diet)
Number of subjects: 7